Contact us
Our Approach
Functional Antibody ScreeningADC TechnologyBiTAC Technology
Pipeline
About us
CareersPartnering
News & Events
Press ReleasesEvents & ConferencesScientific Publications
Contact Us
About us
Careers
Partnering
Pipeline
Science
Functional antibody screening
ADC technology
BiTAC technology
News & events
Press releases
Events & conferences
Scientific publications
Contact Us
ImprintPrivacy policy
News & EventsPress Release

Press Release

December 12, 2024

VERAXA Biotech and Navigo Proteins Initiate Research Collaboration to Establish Pre-Targeting Strategies for Novel Affilin Radio Conjugates

The agreement brings together Navigo Protein’s Affilin® platform with VERAXA’s proprietary click chemistry platform and conjugation expertise

Read more
July 18, 2024

VERAXA Biotech Launches New BiTAC Platform to Develop Breakthrough Antibody Therapies with Unprecedented Safety Features

BiTACs benefit from novel architecture with combinatorial-gated design for cancer targeting and built-in safety features

Read more
May 21, 2024

VERAXA Biotech Announces Formation of Clinical Advisory Board to Support Expansion of Proprietary Pipeline in Oncology

Board adds profound clinical expertise in oncology as well as expertise across multiple antibody-based therapeutic modalities to VERAXA

Read more